Insulin-like growth factor-1 receptor and ligand targeting in head and neck squamous cell carcinoma

详细信息    查看全文

• 作者：Mark G. Slomiany ; Leigh Ann Black ; Megan M. Kibbey ; Melissa A. Tingler ; Terry A. Day ; Steven A. Rosenzweig
• 关键词：Insulin-like growth factor-1 receptor ; Insulin-like growth factor binding protein-3 ; Epidermal growth factor ; Head and neck squamous cell carcinoma ; Receptor tyrosine kinase inhibitors ; NVP-AEW541 ; AG1478
• 刊名：Cancer Letters
• 出版年：2007
• 出版时间：18 April 2007
• 年：2007
• 卷：248
• 期：2
• 页码：269-279
• 全文大小：597 K

文摘

IGF-1 receptor (IGF-1R) signaling is associated with increased tumorigenesis of epithelial cancers. In light of recent epidemiological studies correlating high circulating levels of IGF-1 with increased risk of second primary tumors (SPTs) of the head and neck, we examined IGF system and epidermal growth factor receptor (EGFR) expression in human head and neck squamous cell carcinoma (HNSCC) matched pairs and a cross-section of HNSCC cell lines. Employing the latter, we demonstrated that IGF-1 stimulated S-phase transition in a PI 3-K/Akt and Erk-dependent manner in 5 of 8 cell lines, with Erk activation being dependent upon EGFR kinase activity. IGF-1 stimulated thymidine incorporation was inhibited by treatment with IGFBP-3, the IGF-1R tyrosine kinase inhibitor NVP-AEW541, or the EGFR tyrosine kinase inhibitor AG1478. Combining IGFBP-3 with NVP-AEW541 or AG1478 abrogated IGF-1 responses at 10-fold lower doses than either compound alone. These results demonstrate the potential for co-targeting the IGF system and EGFR in HNSCC.